(via NewsDirect)
Contact Details
+61 413 713 744
jonathan@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.
Copyright (c) 2023 TheNewswire - All rights reserved., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | 0.00% | -25.00% | -14.29% |
16/05 | Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial | MT |
25/03 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
(via NewsDirect)
+61 413 713 744
jonathan@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.
Copyright (c) 2023 TheNewswire - All rights reserved., source
1st Jan change | Capi. | |
---|---|---|
-14.29% | 63.49L | |
+33.05% | 5.08TCr | |
+0.15% | 4.28TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.95TCr | |
+10.62% | 2.61TCr | |
-22.17% | 1.91TCr | |
+8.48% | 1.31TCr | |
+27.20% | 1.22TCr | |
+24.53% | 1.21TCr |